Conference Proceedings
INFLUENCE OF BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS ON EFFICACY OF AN ORAL, SELECTIVE TYK2 INHIBITOR, BMS-986165, IN PATIENTS WITH PLAQUE PSORIASIS IN A PHASE 2 TRIAL
Kenneth Gordon, Kim Papp, Melinda Gooderham, Diamant Thaci, Peter Foley, Akimichi Morita, Sudeep Kundu, Renata Kisa, Andrew Napoli, Subhashis Banerjee
Psoriatic arthritis | BMJ PUBLISHING GROUP | Published : 2019
Grants
Funding Acknowledgements
Editorial/medical writing: Michele Springer and Nicole Draghi, Caudex; funding: Bristol-Myers Squibb